Literature DB >> 30328604

Assessment of hepatitis B immunization programme among school students in Qatar.

Hamad Al-Romaihi1, Hana Al-Masri1, Sherine Shawky2, Mohammed Al Thani1, Salah Al Awaidy3, Mohamed Ahmed Janahi4, Moutaz Derbala4, Khalid Al-Ansari4, Robert Allison5.   

Abstract

BACKGROUND: In 2010, Qatar adopted the target of reducing hepatitis B prevalence to < 1% in children by 2015. The World Health Organization Region for the Eastern Mediterranean is identified with intermediate hepatitis B virus (HBV) endemicity, ranging from 2% to 7%. It is estimated that 4.3 million individuals are living with HBV infection in the Region. AIMS: This study was conducted to assess hepatitis B seroprevalence in children, hepatitis B vaccination coverage, potential exposure to risk factors, and knowledge among parents/guardians about hepatitis B infection.
METHODS: We carried out this cross-sectional study in Qatar during the academic year 2015/16. Multistage cluster sampling was used to select a nationally representative sample of 2735 grade 1 school students aged ≥ 5 years. Blood was collected by finger prick and tested using the point-of-care test/rapid test. A self-administered, precoded questionnaire was used to assess parent/guardian knowledge about HBV and collect information on the child's HBV vaccination coverage.
RESULTS: All blood samples were HBsAg negative. Qataris had a vaccination card and were totally vaccinated but 17.7% of non-Qataris did not hold a vaccination card and most parents/guardians were not aware of the vaccination status of their children. Children were exposed to various hepatitis B risk practices. Knowledge about hepatitis B among parents/ guardians was low.
CONCLUSIONS: Qatar has averted the hepatitis B threat and maintained high vaccination coverage for children.
Copyright © World Health Organization (WHO) 2018. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license (https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Entities:  

Keywords:  Qatar; children; hepatitis B; seroprevalence; vaccination

Mesh:

Substances:

Year:  2018        PMID: 30328604     DOI: 10.26719/2018.24.8.736

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  2 in total

1.  Vaccination coverage in Qatar: Benchmarking with global figures.

Authors:  Ayman Al-Dahshan; Hamed Hammoud; Mohamad Chehab; Sherif R Omar Osman
Journal:  Qatar Med J       Date:  2019-07-25

Review 2.  Point-of-Care Tests for Hepatitis B: An Overview.

Authors:  Yinzong Xiao; Alexander J Thompson; Jessica Howell
Journal:  Cells       Date:  2020-10-02       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.